SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$3.61
-3.22%
Mkt Cap $426.63M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (10 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+315.5%
Consensus $15.00 vs current $3.61
NASDAQ·Healthcare·Biotechnology
$3.61
-3.22%
Mkt Cap $426.63M
Buy
3
Hold
0
Sell
0
Price Target (10 analysts)
$15.00
Range $15.00 – $15.00
+315.5%
Consensus $15.00 vs current $3.61